Howard Leonhardt

Howard J. Leonhardt is an inventor and serial entrepreneur who has built his career at the intersection of cardiovascular medical devices and regenerative medicine. He holds 21+ U.S. patents (with 100+ patent claims and dozens more pending) for products treating cardiovascular disease. His best-known invention, the TALENT (Taheri-Leonhardt) stent graft developed in the early 1990s, became a leading product worldwide for repairing aortic aneurysms without open surgery; the device was commercialized through his company World Medical Manufacturing Corporation. By his firm's accounting, his inventions have been involved in treating more than 500,000 patients across 60 countries.

In early 1999 Leonhardt founded Bioheart, Inc. (later U.S. Stem Cell), a pioneer in applying adult muscle stem cells to treat heart failure, which he took public. His later inventions include MyoStim Pacers — described as the first heart pacemaker designed to recruit stem cells to the heart — and a range of bioelectric "regeneration" devices. He founded Leonhardt's Launchpads in 2008 as an innovation accelerator focused on the convergence of bioelectrics and biologics for organ regeneration and recovery, and today runs a family of spinouts under Leonhardt Ventures, including BioLeonhardt, CerebraCell, EyeCell, AortaCell, and HairCell (haircellstim.com), where he serves as Founder, Executive Chairman and CEO alongside co-inventor Dr. Jorge Genovese.

Beyond medtech, Leonhardt founded and chairs The California Stock Exchange (Cal-X), positioned as a "social good impact" exchange, along with Cal-X Crowdfund Connect and the Cal-X Stars Business Accelerator, and co-leads the Startup California initiative. He also operates Leonhardt Vineyards in Sonoma County, the parent LLC under which Leonhardt Ventures does business.

Leonhardt's formal education includes a Diploma in International Trade from Anoka Technical College and coursework at the University of Minnesota and Anoka-Ramsey College. He holds an honorary Doctorate in Biomedical Engineering from the University of Northern California and is an honorary alumnus of the University of Florida and Florida International University. He was named South Florida Entrepreneur of the Year (2003) and State of Florida Entrepreneur of the Year (2004).

• Invests almost exclusively in regenerative medtech built on the "convergence of bioelectrics and biologics" for organ regeneration and recovery — heart, brain, eye, skin, bladder, hair, teeth, and related tissue.
• Operates as a venture-creation lab / angels network, not a passive fund — most portfolio companies were founded or co-founded by Leonhardt himself; his angels network has "raised and put to work over $145 million in ~28–32 companies."
• Early / seed-stage focus, typically incubating companies through Leonhardt's Launchpads accelerator and Cal-X Stars.
• Says yes to ventures aligned with a patented technology platform (bioelectric stimulation + micro-pump stem-cell delivery) and "social good impact" outcomes — the ethos behind Cal-X and the "regenerative economy" framing.
• Values a strong IP position and clinical pathway; his own companies (e.g., HairCell) are built around provisional/issued patents and clinical studies.